Search

everythinglearnresearchcommunity

for

Search:↓

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Upadacitinib improved multiple immune-related conditions in one patient.

New itaconate prodrugs improve its absorption and effectiveness for treating inflammation.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Papain from papaya may help treat cardiovascular diseases by breaking down fibrin.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

5-Alpha reductase inhibitors help treat enlarged prostate but may cause sexual side effects.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

5-alpha reductase inhibitors may increase depression risk by 31%, but results vary based on comparison groups.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.